Member Since April 2024
Skills
Entrepreneur
Innovation
Start-Ups
About
I have over 25 years of biopharmaceutical experience and have spent the last 10 years leading startups. My most recent role as the CEO of Belhaven is focused on making emergency medicines more patient friendly and accessible to patients.
Scott Lyman
CEO
Published content
article
The shifting consumer behaviors within the pharmaceutical sector are indicative of a broader transformation in the role of pharmaceutical companies in society.
Company details
Belhaven Biopharma
Company bio
Belhaven Biopharma is developing a portfolio of dry powder nasal medicines to provide convenient, safe, and rapid treatments in emergency situations.